Technology Offers

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Pressure pulsation and vibration damping in reciprocating compressors manifold - Pressure pulsation damping in the reciprocating compressor manifolds, compressor stations and gas transmission pipelines - Reduction of the gas transmission pipelines vibrations

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Synthesis of bioactive compounds We offer developed methods for the synthesis of known active substances by reaction in the presence of ultrasound and other eco-friendly methods. We also offer synthesis on request or a ready library of bioactive compounds with anti-cancer effect.

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Construction adhesives for anchoring in concrete and masonry substrates The present invention relates to epoxy adhesives and vinyl ester adhesives for construction applications. They are characterized by high chemical resistance after solidification, very low primary and secondary shrinkage, also a short setting time at positive temperatures and a relatively short setting time at negative temperatures. The novelty in relation to commercial solutions is the composition of adhesives, which allows their application in temperatures below -10 C.

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Bioactive haemostatic agents with advanced biological properties The technology comprises the obtainment of physically crosslinked aerogel with a unique chemical structure, which is responsible for the exceptional sorption capacity and antioxidant properties leading to scavenging of reactive radicals, especially oxygen (ROSS). Biomaterials are obtained from resources of fungal and plant origin. The use of biocompatible substances eliminates the use of toxic reagents, so the method of preparation is in line with the limitations of Green Chemistry.

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

A modern form of formulation on burn wound healing, containing bioactive lavender oil (Lavandula angustifolia)The subject of the invention will be a nanoformulation containing as a therapeutic ingredient bioactive lavender oil (Lavandula angustifolia).

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Vertical centrifugal honey dehydrator (VCHD)/honey dryer Proposed VCHD allows the beekeepers (owners of small and medium apiaries) to dehydrate honey faster and cheaper than with the use of products available on the market nowadays. The cost of the VCHD is also lower than the cost of typical commercial honey dehydrators. What’s more. The VCHD is also multifunctional. It allows for: creaming honey, drying pollen and, after minor reconfiguration, it can act as a honey centrifuge.

Laser Consult Ltd. posted this:

Multifunctional Syringe (Protected Healthcare Workers)This is a medical device, is a syringe, which solves the problem of the danger of infecting patients and health care workers with diseases that can be transmitted by injecting with an already used needle. With this new syringe model, you can apply the drug enormously quickly while protecting yourself. It is intended for a single use with only one use practically possible. The dosage is much easier because it has two measuring scales. The volume is 15ml but can be changed as needed is it can be produced in different sizes. The disinfection mechanism is in the syringe, and one of the novelties is that the needle has no contact with the healthcare worker applying the therapy.

Covid-19 Innovation Challenges by Innoget posted this:

COVID-19 Rapid Diagnostic Kit Designing and developing vaccines, cures and diagnostic kits can be considered as the first priority for every country which is in the first line of fighting against coronavirus. Now there is only PCR test and IgG/IgM test for COVID-19 assessment. One of the most important problems of this diagnostic test is the time needed by the device to detect infected persons. This problem makes big companies in the field of pharmaceutical and medical devices manufacturing to design and develop rapid test kits. Our research team found that there are some specific proteins on the viral membrane which can make some reagents undergo a specific chemical reaction. Every reaction has a specific product related to substrates, so by detection of products with indicator reagents we are able to identify the virus in saliva. Indicator reagents usually change the reaction mixture color so by color change we can approve that the person is infected by COVID-19.

Alireza Daneshvar posted this:
Pharmacy Student and Researcher at Tehran University of Medical Sciences

COVID-19 Rapid Diagnostic Kit Designing and developing vaccines, cures and diagnostic kits can be considered as the first priority for every country which is in the first line of fighting against coronavirus. Now there is only PCR test and IgG/IgM test for COVID-19 assessment. One of the most important problems of this diagnostic test is the time needed by the device to detect infected persons. This problem makes big companies in the field of pharmaceutical and medical devices manufacturing to design and develop rapid test kits. Our research team found that there are some specific proteins on the viral membrane which can make some reagents undergo a specific chemical reaction. Every reaction has a specific product related to substrates, so by detection of products with indicator reagents we are able to identify the virus in saliva. Indicator reagents usually change the reaction mixture color so by color change we can approve that the person is infected by COVID-19. The advantages of using saliva include: specimen collection can be done without a healthcare professional no additional equipment such as swabs or transport media are needed as nasopharyngeal specimens can be 'uncomfortable' use of saliva-based testing may encourage recruits to clinical trials of vaccines. So far two prototypes have been designed: 1) For Home Testing: Disposable test kits where an individual adds a saliva sample into a vial containing the indicator reagent, the presence of the COVID-19 virus is indicated by a positive test as shown by a colour change. 2) Reusable Low Cost Test Kits for Healthcare Professionals: Where there is a low concentration of virus in saliva, for example in the first days after infection, viral proteins can be concentrated using a saliva condensation function. In this situation, multiple samples of saliva are placed into a device which can condensate the samples to increase concentration of any virus present. After the test has been completed, the vessel can be disinfected for ready for re-use. One of the most important properties of this approach is a much lower error rate than has been found in other devices. (errors found in other tests are in various submitted articles to different journals). The re-usable nature of this professional test could make it a practical solution for low-income countries where large scale expensive PCR testing is not an option.

Covid-19 Innovation Challenges by Innoget posted this:

Expertise in molecular biology either experimentally or computationally The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.

IBB-UAB posted this:

Expertise in molecular biology either experimentally or computationally The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.

TEC Edmonton posted this:

Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion Inhibitors A series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.

Covid-19 Innovation Challenges by Innoget posted this:

Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion Inhibitors A series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.

Pascal Mayer posted this:
CEO at Alphanosos

Alphanosos - Leader in botanical plant-based natural antimicrobial control, well-being and medicine Alphanosos is active in animal feed, medical foods, and pharma, and with the right venture partners, to become a leader in botanical plant-based natural antimicrobial control, well-being and medicine through its R&D based on proprietary Artificial Intelligence. Alphanosos’ first patent-pending discoveries are incorporated into commercial products and generate its first revenues.

Pascal Mayer posted this:
CEO at Alphanosos

Alphanosos rapid discovery technology against COVID 19 Alphanosos’ AI guided rapid discovery technology, validated in antimicrobials and anticancer, is expected to develop within 3 weeks of experimental work with a virology partner an anti-COVID-19 treatment composed of a synergistic mix of extracts of edible plants, chosen for being available in large amounts and with good traceability. Such treatment is, therefore, and also thanks to the innovative elaboration process, immediately available to enter large curative clinical trials, to be followed by country-wide deployment in a matter of weeks, for curative and for preventive goals (because of safety which is guaranteed by the edible nature of the mix).

Technology Offers

Innovation Resources

Sitemaps

Support

Company

Top Posts Categories

Recognitions

Technology Offers

Recognitions

Follow us